Fulcrum Therapeutics, Inc

(NASDAQ:FULC)

Latest On Fulcrum Therapeutics, Inc (FULC):

Date/Time Type Description Signal Details
2023-05-24 17:06 ESTNewsFulcrum Therapeutics: FSHD Steadily Advancing In Phase 3, Optionality With SCDN/A
2023-05-16 00:01 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q1 2023 Earnings Call TranscriptN/A
2023-05-15 10:14 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $0.3M misses by $0.68MN/A
2023-05-15 10:14 ESTNewsFulcrum Therapeutics appoints new executive chiefN/A
2023-05-05 01:13 ESTNewsFulcrum slips as Goldman Sachs downgrades on limited catalyst pathN/A
2023-04-25 17:38 ESTNewsFulcrum Therapeutics: Barrage Of Bad News In 2023 But Key Catalysts RemainN/A
2023-04-05 22:41 ESTNewsFulcrum Therapeutics CFO resignsN/A
2023-03-10 23:32 ESTNewsFulcrum Therapeutics downgraded to neutral at Credit Suisse on sickle cell candidateN/A
2023-03-10 23:31 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 16:52 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.50 misses by $0.01, revenue of $0.7M misses by $1.19MN/A
2023-03-09 16:52 ESTNewsFulcrum plunges 23% after Q4 update as medical chief departsN/A
2023-02-24 17:52 ESTNewsFulcrum Therapeutics plunges 55% on clinical hold for sickle cell treatmentsN/A
2023-02-13 20:23 ESTNewsFulcrum's Losmapimod: A Potential Aid, But Its Ability To Modify The Disease Remains UncertainN/A
2023-01-18 07:27 ESTNewsFulcrum Therapeutics shares slide after pricing $125M upsized stock offeringN/A
2023-01-17 20:15 ESTNewsFulcrum Therapeutics commences $100M underwritten public offering of sharesN/A
2023-01-04 19:34 ESTNewsFulcrum Therapeutics names new CEO and provides business outlookN/A
2022-11-12 22:51 ESTNewsFulcrum Therapeutics, Inc. (FULC) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 12:30 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.51 beats by $0.11, revenue of $1.18M misses by $1.36MN/A
2022-11-07 19:00 ESTNewsFulcrum Therapeutics names new chief medical officer, chief scientific officerN/A
2022-08-16 08:01 ESTNewsFulcrum Therapeutics stock dips on offering of $75M sharesN/A
2022-08-16 08:01 ESTNewsFulcrum prices ~$75M stock offeringN/A
2022-08-12 02:43 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 09:44 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.83 misses by $0.17, revenue of $1.9M misses by $1.06MN/A
2022-07-11 19:26 ESTNewsFulcrum Therapeutics says chief medical officer Christopher Morabito to leaveN/A
2022-07-06 05:55 ESTNewsFulcrum begins dosing in late-stage study of losmapimod for rare muscle disorderN/A
2022-06-28 04:00 ESTNewsFulcrum Therapeutics: Value Loss On SCD Data Update Is TellingN/A
2022-06-10 23:46 ESTNewsFulcrum crashes 48% after announcing early-stage data sickle cell disease candidateN/A
2022-06-08 03:53 ESTNewsFulcrum gains as Merck ends deal for lung disease candidatesN/A
2022-05-10 06:03 ESTNewsFulcrum Therapeutics' (FULC) CEO Bryan Stuart on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 10:26 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $2.6M misses by $1.34MN/A
2022-03-08 13:53 ESTNewsFulcrum rises as Oppenheimer highlights sickle cell disease candidateN/A
2022-03-03 11:48 ESTNewsFulcrum Therapeutics GAAP EPS of -$0.58 beats by $0.09, revenue of $5.06M beats by $1.54MN/A
2022-03-03 11:48 ESTNewsFulcrum plans phase 3 trial of losmapimod to treat rare muscle disorderN/A
2022-03-03 11:48 ESTNewsFulcrum Therapeutics, Inc.'s (FULC) CEO Bryan Stuart On Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-11 21:58 ESTNewsFulcrum Therapeutics grants inducement options to one new employeeN/A
2022-01-08 15:26 ESTNewsBiogen, Galapagos and Ultragenyx among key biotech calls at Morgan Stanley for 2022N/A
2022-01-04 13:05 ESTNewsFulcrum Therapeutics hires CFON/A
2021-11-06 20:44 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q3 2021 results - Earnings Call TranscriptN/A
2021-09-03 15:55 ESTNewsFulcrum Therapeutics: Multiple Interesting Programs, Needs A Better Entry PointN/A
2021-08-12 17:25 ESTNewsFulcrum Therapeutics raises $125M via equity offeringN/A
2021-08-11 21:00 ESTNewsBluebird bio price target cut; Fulcrum upgraded as Morgan Stanley shakes up SCD coverageN/A
2021-08-11 01:17 ESTNewsFulcrum Therapeutics surges on early-stage results for sickle cell disease therapyN/A
2021-08-11 01:16 ESTNewsFulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-11 01:15 ESTNewsFulcrum Therapeutics more than doubles as Stifel raises price targetN/A
2021-08-11 01:15 ESTNewsFulcrum Therapeutics shares under pressure after $100M capital raiseN/A
2021-07-21 09:26 ESTNewsFulcrum Therapeutics reports results mid-stage losmapimod study in rare disabling diseaseN/A
2021-07-21 09:26 ESTNewsStifel nearly doubles Fulcrum price target, assumes 354% upsideN/A
2021-07-21 09:24 ESTNewsMRIN, ALT, FLXN and FULC among after-hours moversN/A
2021-05-06 12:07 ESTNewsFulcrum Therapeutics beats on revenueN/A
2021-05-06 12:06 ESTNewsFulcrum Therapeutics has a new medical chiefN/A

About Fulcrum Therapeutics, Inc (FULC):

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-6058, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and ß-thalassemia. The company is also discovering drug targets for the treatments of muscle, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

FULC Quotes by TradingView

See Advanced Chart

General

  • Name Fulcrum Therapeutics, Inc
  • Symbol FULC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 73
  • Fiscal Year EndDecember
  • IPO Date2019-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Web URLhttp://www.fulcrumtx.com
View More

Valuation

  • Trailing PE 267
  • Price/Sales (Trailing 12 Mt.) 34.37
  • Price/Book (Most Recent Quarter) 4.11
  • Enterprise Value Revenue 31.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.87
  • Next Year EPS Estimate -$3.06
  • Next Quarter EPS Estimate -$0.66
  • Operating Margin -812%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 8.82 million
  • Earnings Per Share -$50.40
  • Revenue Per Share $0.35
  • Gross Profit -46839000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 405.79 million
  • EBITDA -67074000
  • PE Ratio -26.37
  • Analyst Target Price $18
  • Book Value Per Share $4.53
View More

Share Statistics

  • Shares Outstanding 32.67 million
  • Shares Float 18.96 million
  • % Held by Insiders 3552%
  • % Held by Institutions 76.11%
  • Shares Short 690946
  • Shares Short Prior Month 724097
  • Short Ratio 4.81
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $22.39
  • 52 Week Low $7.01
  • 50 Day Moving Average 12.75
  • 200 Day Moving Average 11.21
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Fulcrum Therapeutics, Inc (FULC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Fulcrum Therapeutics, Inc (FULC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$4.23 million-$0.63-$0.7313.1%
2020-09-302020-11-10$N/A-$0.70-$0.64-9.8%
2020-06-302020-08-11$N/A-$0.66-$0.7511.61%
2020-03-312020-05-13$750000-$0.81-$0.76-6.58%
2019-12-312020-03-05$N/A-$0.71-$0.8819.62%
2019-09-302019-11-14$N/A-$0.97-$0.72-34.72%
2019-06-302019-08-26$N/A-$0.71-$0.755.33%

Fulcrum Therapeutics, Inc (FULC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fulcrum Therapeutics, Inc (FULC) Chart:

Fulcrum Therapeutics, Inc (FULC) News:

Below you will find a list of latest news for Fulcrum Therapeutics, Inc (FULC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fulcrum Therapeutics, Inc (FULC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-02-2010CALL0 00TRUE00
2026-02-2020CALL0 00TRUE00
2026-02-2030CALL0 00TRUE00
2026-02-2040CALL0 00TRUE00
2026-02-2050CALL0 00TRUE00
2026-02-2060CALL0 00TRUE00
2026-02-2070CALL0 00TRUE00
2026-02-2080CALL0 00TRUE00
2026-02-2092.7CALL0 2266.84TRUE00
2026-02-20100.8CALL0 7370.06TRUE00
2026-02-20111CALL4 49155.05FALSE10
2026-02-20120.63CALL1 151154.17FALSE0.630
2026-02-20130.65CALL0 11252.76FALSE00
2026-02-20140.55CALL0 23249.4FALSE00
2026-02-20150.45CALL0 16236.07FALSE00
2026-02-20162CALL0 1340.25FALSE00
2026-02-20170CALL0 0331.14FALSE00
2026-02-20180CALL0 0420.79FALSE00
2026-02-20190CALL0 0408.69FALSE00
2026-02-20200.05CALL0 2427.89FALSE00
2026-02-20210CALL0 0445.73FALSE00
2026-02-20220CALL0 0462.37FALSE00
2026-02-20230CALL0 0477.97FALSE00
2026-02-20240CALL0 0492.65FALSE00
2026-02-20250CALL0 0506.5FALSE00
2026-02-20260CALL0 0519.61FALSE00
2026-02-20270CALL0 0493.81FALSE00
2026-02-20280CALL0 0543.9FALSE00
2026-02-2010PUT0 00FALSE00
2026-02-2020PUT0 00FALSE00
2026-02-2030PUT0 00FALSE00
2026-02-2040PUT0 0983.32FALSE00
2026-02-2050PUT0 01057.79FALSE00
2026-02-2060.05PUT0 1869.31FALSE00
2026-02-2070.15PUT0 126223.01FALSE00
2026-02-2080.25PUT0 256250.45FALSE00
2026-02-2090.71PUT0 23308.06FALSE00
2026-02-20100.69PUT13 217164.66FALSE0.690
2026-02-20111.24PUT2 21172.62TRUE1.240
2026-02-20121.83PUT0 2331.79TRUE00
2026-02-20132.2PUT0 4153.23TRUE00
2026-02-20140PUT0 0208.2TRUE00
2026-02-20150PUT0 0180.42TRUE00
2026-02-20160PUT0 0267.74TRUE00
2026-02-20170PUT0 0281.21TRUE00
2026-02-20180PUT0 0159.45TRUE00
2026-02-20190PUT0 0261.16TRUE00
2026-02-20200PUT0 0360.25TRUE00
2026-02-20210PUT0 00TRUE00
2026-02-20220PUT0 0307.05TRUE00
2026-02-20230PUT0 0303.67TRUE00
2026-02-20240PUT0 00TRUE00
2026-02-20250PUT0 0375.2TRUE00
2026-02-20260PUT0 00TRUE00
2026-02-20270PUT0 0367.57TRUE00
2026-02-20280PUT0 0377.96TRUE00
2026-03-2010CALL0 00TRUE00
2026-03-2020CALL0 00TRUE00
2026-03-2030CALL0 00TRUE00
2026-03-2040CALL0 00TRUE00
2026-03-2050CALL0 00TRUE00
2026-03-2060CALL0 00TRUE00
2026-03-2070CALL0 00TRUE00
2026-03-2082.75CALL0 3112.17TRUE00
2026-03-2091.9CALL0 18107.07TRUE00
2026-03-20101.93CALL5 19108.74TRUE1.930
2026-03-20111.59CALL0 55121.14FALSE00
2026-03-20121.3CALL1 90124.42FALSE1.30
2026-03-20131.3CALL0 24118.32FALSE00
2026-03-20140.9CALL0 53112.19FALSE00
2026-03-20150.6CALL0 287172.79FALSE00
2026-03-20163.3CALL0 3167.21FALSE00
2026-03-20170CALL0 0179.54FALSE00
2026-03-20180.3CALL0 14173.67FALSE00
2026-03-20190CALL0 0183.68FALSE00
2026-03-20200.8CALL0 30192.92FALSE00
2026-03-20210CALL0 0219.32FALSE00
2026-03-20220CALL0 0227.54FALSE00
2026-03-20230CALL0 0235.24FALSE00
2026-03-20240CALL0 0242.49FALSE00
2026-03-20250CALL0 0249.33FALSE00
2026-03-20260CALL0 0255.8FALSE00
2026-03-20270CALL0 0243.09FALSE00
2026-03-20280CALL0 0267.79FALSE00
2026-03-2010PUT0 00FALSE00
2026-03-2020PUT0 00FALSE00
2026-03-2030PUT0 0887.81FALSE00
2026-03-2040PUT0 0666.93FALSE00
2026-03-2050PUT0 0540.05FALSE00
2026-03-2060PUT0 0330.31FALSE00
2026-03-2070.68PUT5 6188.4FALSE0.680
2026-03-2080PUT0 0138.43FALSE00
2026-03-2091.09PUT0 24214.42FALSE00
2026-03-20101.48PUT5 14144.75FALSE1.480
2026-03-20112.2PUT0 36140.17TRUE00
2026-03-20122.3PUT0 11117.92TRUE00
2026-03-20132.65PUT0 11121.14TRUE00
2026-03-20143.69PUT0 2150.59TRUE00
2026-03-20150PUT0 0130.41TRUE00
2026-03-20160PUT0 0130.13TRUE00
2026-03-20170PUT0 0141.78TRUE00
2026-03-20180PUT0 0147.32TRUE00
2026-03-20190PUT0 0145.85TRUE00
2026-03-20200PUT0 0148.38TRUE00
2026-03-20210PUT0 0162.69TRUE00
2026-03-20220PUT0 0140.43TRUE00
2026-03-20230PUT0 0136.08TRUE00
2026-03-20240PUT0 0142.12TRUE00
2026-03-20250PUT0 0147.86TRUE00
2026-03-20260PUT0 0174.32TRUE00
2026-03-20270PUT0 0202.66TRUE00
2026-03-20280PUT0 0145.98TRUE00
2026-06-1810CALL0 00TRUE00
2026-06-1820CALL0 00TRUE00
2026-06-1830CALL0 00TRUE00
2026-06-1840CALL0 00TRUE00
2026-06-1856.5CALL0 390.31TRUE00
2026-06-1860CALL0 070.18TRUE00
2026-06-1874.2CALL0 778.34TRUE00
2026-06-1884.3CALL0 1256.65TRUE00
2026-06-1893.6CALL0 599.44TRUE00
2026-06-18100CALL0 0109.35TRUE00
2026-06-18112.33CALL0 9133.2FALSE00
2026-06-18121.41CALL0 10597.11FALSE00
2026-06-18132CALL0 1096.21FALSE00
2026-06-18142.25CALL0 4107.3FALSE00
2026-06-18150.96CALL0 44107.24FALSE00
2026-06-18161.09CALL0 23109FALSE00
2026-06-18172.3CALL0 4105.6FALSE00
2026-06-18182.1CALL0 11129.41FALSE00
2026-06-18190CALL0 0131.17FALSE00
2026-06-18202.1CALL0 1132.37FALSE00
2026-06-18211.7CALL0 1133.06FALSE00
2026-06-18220CALL0 0133.29FALSE00
2026-06-18230CALL0 0135.33FALSE00
2026-06-18240CALL0 0137.06FALSE00
2026-06-18250CALL0 0138.5FALSE00
2026-06-18260CALL0 0139.67FALSE00
2026-06-18270CALL0 0140.59FALSE00
2026-06-18280CALL0 0143.76FALSE00
2026-06-1810PUT0 0834.36FALSE00
2026-06-1820PUT0 0734.99FALSE00
2026-06-1830PUT0 0309.05FALSE00
2026-06-1840PUT0 0264.23FALSE00
2026-06-1850PUT0 0308.06FALSE00
2026-06-1860PUT0 0249.04FALSE00
2026-06-1870PUT0 0115.81FALSE00
2026-06-1881.4PUT0 2112.61FALSE00
2026-06-1892.1PUT0 23113.9FALSE00
2026-06-18102.45PUT0 121128.58FALSE00
2026-06-18113.1PUT0 12119.42TRUE00
2026-06-18120PUT0 0104.25TRUE00
2026-06-18133.5PUT0 10119.29TRUE00
2026-06-18144.2PUT0 11121.85TRUE00
2026-06-18156.1PUT0 2119.24TRUE00
2026-06-18160PUT0 0121.46TRUE00
2026-06-18170PUT0 0122.77TRUE00
2026-06-18180PUT0 0123.28TRUE00
2026-06-18190PUT0 0120.89TRUE00
2026-06-18200PUT0 0122.09TRUE00
2026-06-18210PUT0 0120.41TRUE00
2026-06-18220PUT0 0115.39TRUE00
2026-06-18230PUT0 0114.54TRUE00
2026-06-18240PUT0 0121.35TRUE00
2026-06-18250PUT0 0116.81TRUE00
2026-06-18260PUT0 0129.04TRUE00
2026-06-18270PUT0 0117.57TRUE00
2026-06-18280PUT0 0117.36TRUE00
2026-09-1820CALL0 00TRUE00
2026-09-1830CALL0 00TRUE00
2026-09-1840CALL0 082.68TRUE00
2026-09-1850CALL0 00TRUE00
2026-09-1860CALL0 00TRUE00
2026-09-1870CALL0 056.63TRUE00
2026-09-1884.8CALL0 194.9TRUE00
2026-09-1890CALL0 080.68TRUE00
2026-09-18100CALL0 0128.51TRUE00
2026-09-18110CALL0 0112.59FALSE00
2026-09-18123.6CALL0 1122.49FALSE00
2026-09-18130CALL0 085.74FALSE00
2026-09-18140CALL0 0125.92FALSE00
2026-09-18152.5CALL0 20104.75FALSE00
2026-09-18162.07CALL0 2382.23FALSE00
2026-09-18171.8CALL0 199.78FALSE00
2026-09-18181.8CALL0 1115.97FALSE00
2026-09-1820PUT0 0258.38FALSE00
2026-09-1830PUT0 0192.63FALSE00
2026-09-1840PUT0 0161.21FALSE00
2026-09-1850PUT0 0151.15FALSE00
2026-09-1860PUT0 0108.9FALSE00
2026-09-1870PUT0 0101.32FALSE00
2026-09-1880PUT0 0121.94FALSE00
2026-09-1892.45PUT1 0114.73FALSE2.450
2026-09-18100PUT0 0111.35FALSE00
2026-09-18110PUT0 0118.45TRUE00
2026-09-18120PUT0 0119.04TRUE00
2026-09-18130PUT0 0112.46TRUE00
2026-09-18140PUT0 0109.84TRUE00
2026-09-18156.8PUT0 1112.48TRUE00
2026-09-18160PUT0 093.38TRUE00
2026-09-18170PUT0 0111.24TRUE00
2026-09-18180PUT0 095.09TRUE00
2027-01-1510CALL0 00TRUE00
2027-01-15212.6CALL0 10TRUE00
2027-01-15311.26CALL0 190.97TRUE00
2027-01-1549.7CALL0 594.26TRUE00
2027-01-1556.63CALL0 14084.28TRUE00
2027-01-1575.24CALL0 593.88TRUE00
2027-01-15104.47CALL0 56101.57TRUE00
2027-01-15124CALL0 21104.1FALSE00
2027-01-15153CALL0 3954104.59FALSE00
2027-01-15172.75CALL0 17103.52FALSE00
2027-01-15200CALL0 0105.03FALSE00
2027-01-15220CALL0 0174.7FALSE00
2027-01-15251.47CALL0 41182.25FALSE00
2027-01-15271.71CALL0 121127.69FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 00FALSE00
2027-01-1530.4PUT0 200FALSE00
2027-01-1540PUT0 2441.28FALSE00
2027-01-1551.45PUT0 3298.12FALSE00
2027-01-1571.86PUT0 0217.04FALSE00
2027-01-15100PUT0 0109.12FALSE00
2027-01-15120PUT0 0114.91TRUE00
2027-01-15150PUT0 0112.48TRUE00
2027-01-15170PUT0 0113.99TRUE00
2027-01-152010.2PUT0 0113.08TRUE00
2027-01-15220PUT0 0116.37TRUE00
2027-01-15250PUT0 0113.07TRUE00
2027-01-15270PUT0 0118.36TRUE00

Latest FULC Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST48$4.18
Jun 13, 2022 7:59 PM EST10$4.18
Jun 13, 2022 7:59 PM EST100$4.185
Jun 13, 2022 7:59 PM EST100$4.18
Jun 13, 2022 7:59 PM EST112$4.18

Fulcrum Therapeutics, Inc (FULC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2019-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000019009042/0000000000-19-009042-index.htm
2019-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000019009993/0000000000-19-009993-index.htm
2020-06-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000020005645/0000000000-20-005645-index.htm
2020-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1680581/000000000020007385/0000000000-20-007385-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000031506620000982/0000315066-20-000982-index.htm
2020-09-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000089914020000435/0000899140-20-000435-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019806/0000899243-19-019806-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019807/0000899243-19-019807-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319019809/0000899243-19-019809-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2020-01-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320000461/0000899243-20-000461-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320000462/0000899243-20-000462-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002034/0000899243-20-002034-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002035/0000899243-20-002035-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002040/0000899243-20-002040-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320002041/0000899243-20-002041-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016496/0000899243-20-016496-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016497/0000899243-20-016497-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016498/0000899243-20-016498-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016499/0000899243-20-016499-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320016500/0000899243-20-016500-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000090342319000302/0000903423-19-000302-index.htm
2019-05-01DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000091205719000198/0000912057-19-000198-index.htm
2019-06-06DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000091205719000241/0000912057-19-000241-index.htm
2020-02-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000091957420001785/0000919574-20-001785-index.htm
2019-06-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919003793/0001047469-19-003793-index.htm
2019-07-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919004014/0001047469-19-004014-index.htm
2019-07-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000104746919004158/0001047469-19-004158-index.htm
2019-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1680581/000104746919004265/0001047469-19-004265-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000104746919004324/0001047469-19-004324-index.htm
2019-06-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919037024/0001104659-19-037024-index.htm
2019-06-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919037583/0001104659-19-037583-index.htm
2019-07-128-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1680581/000110465919040208/0001104659-19-040208-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040331/0001104659-19-040331-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040333/0001104659-19-040333-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040809/0001104659-19-040809-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040810/0001104659-19-040810-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040811/0001104659-19-040811-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040812/0001104659-19-040812-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040813/0001104659-19-040813-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040814/0001104659-19-040814-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040815/0001104659-19-040815-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040816/0001104659-19-040816-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040817/0001104659-19-040817-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040818/0001104659-19-040818-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040819/0001104659-19-040819-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040820/0001104659-19-040820-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040821/0001104659-19-040821-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040965/0001104659-19-040965-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040966/0001104659-19-040966-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040967/0001104659-19-040967-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040968/0001104659-19-040968-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040969/0001104659-19-040969-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040970/0001104659-19-040970-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040971/0001104659-19-040971-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040972/0001104659-19-040972-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919040973/0001104659-19-040973-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041303/0001104659-19-041303-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000110465920020454/0001104659-20-020454-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000114036119013355/0001140361-19-013355-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000114420419036332/0001144204-19-036332-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312519204925/0001193125-19-204925-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519228512/0001193125-19-228512-index.htm
2019-08-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1680581/000119312519228520/0001193125-19-228520-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519262065/0001193125-19-262065-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312519325397/0001193125-19-325397-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520001768/0001193125-20-001768-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520025424/0001193125-20-025424-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520025429/0001193125-20-025429-index.htm
2020-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520063092/0001193125-20-063092-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1680581/000119312520124813/0001193125-20-124813-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1680581/000119312520124825/0001193125-20-124825-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520165696/0001193125-20-165696-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520166654/0001193125-20-166654-index.htm
2020-06-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000119312520175588/0001193125-20-175588-index.htm
2020-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000119312520177487/0001193125-20-177487-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520181057/0001193125-20-181057-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000119312520197820/0001193125-20-197820-index.htm
2020-08-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1680581/000119312520215668/0001193125-20-215668-index.htm
2020-08-11POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1680581/000119312520215674/0001193125-20-215674-index.htm
2020-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1680581/000119312520219029/0001193125-20-219029-index.htm
2019-07-15CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1680581/000135445719000348/0001354457-19-000348-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1680581/000138713120001784/0001387131-20-001784-index.htm
2019-06-05DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1680581/000141057819000287/0001410578-19-000287-index.htm
2019-08-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459019032952/0001564590-19-032952-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459019043359/0001564590-19-043359-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459019043378/0001564590-19-043378-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020008800/0001564590-20-008800-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1680581/000156459020008951/0001564590-20-008951-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020014860/0001564590-20-014860-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020024846/0001564590-20-024846-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459020024866/0001564590-20-024866-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1680581/000156459020039117/0001564590-20-039117-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1680581/000156459020039121/0001564590-20-039121-index.htm
2016-07-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058116000001/0001680581-16-000001-index.htm
2017-05-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058117000001/0001680581-17-000001-index.htm
2017-07-25D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058117000002/0001680581-17-000002-index.htm
2018-09-05DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058118000002/0001680581-18-000002-index.htm
2020-06-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1680581/000168058120000001/0001680581-20-000001-index.htm
2019-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999519001628/9999999995-19-001628-index.htm
2020-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520001702/9999999995-20-001702-index.htm
2020-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520002111/9999999995-20-002111-index.htm
2020-08-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1680581/999999999520002175/9999999995-20-002175-index.htm
2019-05-13SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1680581/999999999719004388/9999999997-19-004388-index.htm
2019-06-20SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1680581/999999999719005683/9999999997-19-005683-index.htm

Fulcrum Therapeutics, Inc (FULC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fulcrum Therapeutics, Inc (FULC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3552%
Institutional Ownership: 7611%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-19Owen B. WallaceChief Scientific OfficerSell6,088.0020.00121,760.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-05-26Owen B. WallaceChief Scientific OfficerSell412.0020.008,240.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27Owen B. WallaceChief Scientific OfficerSell448.0020.008,960.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28Owen B. WallaceChief Scientific OfficerSell2,232.0020.0044,640.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-06-30Owen B. WallaceChief Scientific OfficerSell141.0020.002,820.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-07-08Owen B. WallaceChief Scientific OfficerSell2,951.0020.0059,020.00127,088.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-06-30Owen B. WallaceChief Scientific OfficerBuy141.007.841,105.44127,229.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018121/0000899243-20-018121-index.htm
2020-05-26Owen B. WallaceChief Scientific OfficerBuy412.007.843,230.08127,500.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014416/0000899243-20-014416-index.htm
2020-05-27Owen B. WallaceChief Scientific OfficerBuy448.007.843,512.32127,536.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014552/0000899243-20-014552-index.htm
2020-05-28Owen B. WallaceChief Scientific OfficerBuy2,232.007.8417,498.88129,320.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014719/0000899243-20-014719-index.htm
2020-07-08Owen B. WallaceChief Scientific OfficerBuy2,951.007.8423,135.84130,039.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018817/0000899243-20-018817-index.htm
2020-02-19Owen B. WallaceChief Scientific OfficerBuy6,088.007.8447,729.92133,176.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005299/0000899243-20-005299-index.htm
2020-09-14Owen B. WallaceChief Scientific OfficerBuy6,350.007.8449,784.00133,438.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320024982/0000899243-20-024982-index.htm
2020-05-11Peter G. ThomsonVP Finance & AccountingSell7,500.0016.00120,000.0021,071.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012820/0000899243-20-012820-index.htm
2019-07-22Third Rock Ventures IV, L.P.10% Share HolderBuy81,250.0016.001,300,000.002,343,154.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020029/0000899243-19-020029-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell250.0018.614,653.0028,571.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell2,102.0017.4336,643.3328,821.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-02-24Peter G. ThomsonVP Finance & AccountingSell2,648.0016.1842,856.5630,923.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005958/0000899243-20-005958-index.htm
2020-01-23Peter G. ThomsonVP Finance & AccountingSell262.0018.054,730.1233,571.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-01-23Peter G. ThomsonVP Finance & AccountingSell4,738.0017.1781,371.8333,833.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320002037/0000899243-20-002037-index.htm
2020-07-08Robert J GouldOfficerSell2,500.0020.0050,000.00534,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018815/0000899243-20-018815-index.htm
2020-06-25Robert J GouldOfficerSell2,500.0020.8051,992.00537,345.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017758/0000899243-20-017758-index.htm
2020-06-09Robert J GouldOfficerSell156.0020.003,120.00539,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015959/0000899243-20-015959-index.htm
2020-06-05Robert J GouldOfficerSell3,433.0020.1769,251.16540,001.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015784/0000899243-20-015784-index.htm
2020-06-04Robert J GouldOfficerSell1,300.0020.0426,057.98543,434.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-03Robert J GouldOfficerSell1,500.0020.1330,192.45544,734.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015437/0000899243-20-015437-index.htm
2020-06-02Robert J GouldOfficerSell2,797.0020.0055,940.00546,234.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-06-01Robert J GouldOfficerSell5.0020.00100.00549,031.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015063/0000899243-20-015063-index.htm
2020-05-29Robert J GouldOfficerSell1,390.0020.0827,910.78549,036.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-28Robert J GouldOfficerSell1,919.0020.0138,391.13550,426.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014721/0000899243-20-014721-index.htm
2020-05-26Robert J GouldOfficerSell2,500.0020.0050,000.00552,345.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014415/0000899243-20-014415-index.htm
2020-02-19Robert J GouldOfficerSell2,500.0020.0050,000.00554,845.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320005300/0000899243-20-005300-index.htm
2019-07-22 Sanofi10% Share HolderBuy93,750.0016.001,500,000.00558,035.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020073/0000899243-19-020073-index.htm
2019-07-226 Dimensions Capital, L.P.10% Share HolderBuy118,750.0016.001,900,000.00559,821.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041307/0001104659-19-041307-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy125,000.0016.002,000,000.00589,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22MARK J LEVINDirectorBuy81,250.0016.001,300,000.005,962,202.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041304/0001104659-19-041304-index.htm
2019-07-22Third Rock Ventures III, L.P.10% Share HolderBuy81,250.0016.001,300,000.005,962,202.00https://www.sec.gov/Archives/edgar/data/1680581/000089924319020026/0000899243-19-020026-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy10,000.0014.50144,996.00599,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2019-07-22Casdin Capital, LLC10% Share HolderBuy5,000.0014.5072,499.00604,285.00https://www.sec.gov/Archives/edgar/data/1680581/000110465919041306/0001104659-19-041306-index.htm
2020-07-01Diego CadavidSVP Clinical DevelopmentSell1,071.0018.3019,599.3065,714.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320018278/0000899243-20-018278-index.htm
2020-03-02Diego CadavidSVP Clinical DevelopmentSell315.0018.135,709.5366,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-05-12Diego CadavidSVP Clinical DevelopmentSell1,860.0018.0033,480.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-05-28Diego CadavidSVP Clinical DevelopmentSell600.0020.0012,000.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-05-29Diego CadavidSVP Clinical DevelopmentSell200.0020.044,007.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-02Diego CadavidSVP Clinical DevelopmentSell45.0020.00900.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-03Diego CadavidSVP Clinical DevelopmentSell338.0020.186,819.5966,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-04Diego CadavidSVP Clinical DevelopmentSell226.0020.054,531.2566,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-05Diego CadavidSVP Clinical DevelopmentSell451.0020.189,100.7766,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-06-10Diego CadavidSVP Clinical DevelopmentSell401.0022.008,822.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-25Diego CadavidSVP Clinical DevelopmentSell1,459.0022.0032,098.0066,785.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-06-02Diego CadavidSVP Clinical DevelopmentBuy45.004.83217.3566,830.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-05-29Diego CadavidSVP Clinical DevelopmentBuy200.004.83966.0066,985.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-04Diego CadavidSVP Clinical DevelopmentBuy226.004.831,091.5867,011.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-03-02Diego CadavidSVP Clinical DevelopmentSell1,828.0017.2631,545.2567,100.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320006590/0000899243-20-006590-index.htm
2020-06-03Diego CadavidSVP Clinical DevelopmentBuy338.004.831,632.5467,123.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015245/0000899243-20-015245-index.htm
2020-06-10Diego CadavidSVP Clinical DevelopmentBuy401.004.831,936.8367,186.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320016382/0000899243-20-016382-index.htm
2020-06-05Diego CadavidSVP Clinical DevelopmentBuy451.004.832,178.3367,236.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320015623/0000899243-20-015623-index.htm
2020-05-28Diego CadavidSVP Clinical DevelopmentBuy600.004.832,898.0067,385.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320014722/0000899243-20-014722-index.htm
2020-06-25Diego CadavidSVP Clinical DevelopmentBuy1,459.004.837,046.9768,244.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320017761/0000899243-20-017761-index.htm
2020-05-12Diego CadavidSVP Clinical DevelopmentBuy1,860.004.838,983.8068,645.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320012822/0000899243-20-012822-index.htm
2020-02-03Diego CadavidSVP Clinical DevelopmentSell2,143.0017.3337,141.8368,928.00https://www.sec.gov/Archives/edgar/data/1680581/000089924320003272/0000899243-20-003272-index.htm